In the NMF classification, we find that a molecular sub-cluster of colon cancer cells is specifically sensitive to chemotherapy, BRAF inhibitors, PI3K-mTOR inhibitors and NOTCH inhibitor treatment (Figure 2C, 3B, 3C and 4E). Here, BRAF is linked to colonic neoplasm.